« Development of a flow cytometry-based method to detect neutralising antibodies in SARS-CoV-2 infection  » (2023) One Health & Risk Management , p. 41. Disponible sur: https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/440 (Consulté le: 11 juillet 2026).